» Articles » PMID: 2153931

Neurologic Crises in Hereditary Tyrosinemia

Overview
Journal N Engl J Med
Specialty General Medicine
Date 1990 Feb 15
PMID 2153931
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Hereditary tyrosinemia results from an inborn error in the final step of tyrosine metabolism. The disease is known to cause acute and chronic liver failure, renal Fanconi's syndrome, and hepatocellular carcinoma. Neurologic manifestations have been reported but not emphasized as a common problem. In this paper, we describe neurologic crises that occurred among children identified as having tyrosinemia on neonatal screening since 1970. Of the 48 children with tyrosinemia, 20 (42 percent) had neurologic crises that began at a mean age of one year and led to 104 hospital admissions. These abrupt episodes of peripheral neuropathy were characterized by severe pain with extensor hypertonia (in 75 percent), vomiting or paralytic ileus (69 percent), muscle weakness (29 percent), and self-mutilation (8 percent). Eight children required mechanical ventilation because of paralysis, and 14 of the 20 children have died. Between crises, most survivors regained normal function. We found no reliable biochemical marker for the crises (those we evaluated included blood levels of tyrosine, succinylacetone, and hepatic aminotransferases). Urinary excretion of delta-aminolevulinic acid, a neurotoxic intermediate of porphyrin biosynthesis, was elevated during crises but also during the asymptomatic periods. Electrophysiologic studies in seven patients and neuromuscular biopsies in three patients showed axonal degeneration and secondary demyelination. We conclude that episodes of acute, severe peripheral neuropathy are common in hereditary tyrosinemia and resemble the crises of the neuropathic porphyrias.

Citing Articles

The diagnostic potential of urine in paediatric patients undergoing initial treatment for tuberculous meningitis.

Isaiah S, Westerhuis J, Loots D, Solomons R, Tutu van Furth M, van Elsland S Sci Rep. 2024; 14(1):19471.

PMID: 39174657 PMC: 11341861. DOI: 10.1038/s41598-024-70419-1.


Rescue of glutaric aciduria type I in mice by liver-directed therapies.

Barzi M, Johnson C, Chen T, Rodriguiz R, Hemmingsen M, Gonzalez T Sci Transl Med. 2023; 15(692):eadf4086.

PMID: 37075130 PMC: 10676743. DOI: 10.1126/scitranslmed.adf4086.


Cis- and trans-resveratrol have opposite effects on histone serine-ADP-ribosylation and tyrosine induced neurodegeneration.

Jhanji M, Nageswara Rao C, Massey J, Hope 3rd M, Zhou X, Keene C Nat Commun. 2022; 13(1):3244.

PMID: 35688816 PMC: 9187644. DOI: 10.1038/s41467-022-30785-8.


Clinical and genetic characteristics of two patients with tyrosinemia type 1 in Slovenia - A novel fumarylacetoacetate hydrolase () intronic disease-causing variant.

Sikonja J, Brecelj J, Zerjav Tansek M, Repic Lampret B, Drole Torkar A, Klemencic S Mol Genet Metab Rep. 2022; 30:100836.

PMID: 35242570 PMC: 8856938. DOI: 10.1016/j.ymgmr.2021.100836.


Mechanisms of Neuronal Damage in Acute Hepatic Porphyrias.

Ricci A, Pierro E, Marcacci M, Ventura P Diagnostics (Basel). 2021; 11(12).

PMID: 34943446 PMC: 8700611. DOI: 10.3390/diagnostics11122205.